Chronic pain is a major health problem. Current treatments are ineffective and cause severe side-effects. Efforts to develop better treatments have failed. At Zyneyro we believe that our drug candidates can be part of the solution. Now, we need to ensure human translation, specifically by providing the translational foundation for the Mode-of-Action by probing the expression and function of the target protein PICK1 in human tissue.

The food ingredient companies, Palsgaard and NEXUS, face an opportunity to enter a new and emerging market of plant-based functionality ingredients to be egg replacers. In PIER, the objective is to create novel high quality food applications by partly or fully replacing the eggs used as ingredients in processed foods with plant-based sources that provide similar or improved functionality and sensory properties, are cost-competitive and affordable, reduce climate impact, and respond to consumer trends. A scientific approach is necessary to achieve the highest consumer acceptance ensuring future-proof innovative ingredient solutions. The interdisciplinary and complementary consortium of PIER covers the needed competences critical to fulfill the goals of PIER. PIER creates knowledge on the mechanisms of functional molecules in plant-based material relating to food structures of foams, emulsions, and gels that readily can provide scientists and food manufacturers of bakery, desserts, and food emulsions with basic understanding of the essential properties. The market potential is very high, and we expect to launch commercially viable solutions already during the 4 year project period based on existing market channels. The opportunity is scalable within the current business model of Palsgaard, is supported by NEXUS R & D and will be further expanded.